ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260411.2	ABT-263 (navitoclax)	Skin cutaneous melanoma	0.021048675	Resistant
ENSG00000260411.2	ABT-263 (navitoclax)	Lung squamous cell carcinoma	0.039163288	Sensitive